Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Melanoma × Atorvastatin × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 13 Prostatic Neoplasms 9 Neoplasms 4 Endometrial Neoplasms 3 Colonic Neoplasms 3 Cardiotoxicity 3 Triple Negative Breast Neoplasms 2 Rectal Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Polycystic Ovary Syndrome 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Neoplasm Metastasis 2 Myelodysplastic Syndromes 2 Leukemia, Myeloid, Acute 2 Heart Failure 2 Glioblastoma 2 Endometrial Hyperplasia 2 Colorectal Neoplasms 2 Cardiovascular Diseases 2 Venous Thrombosis 1 Smoking 1 Pulmonary Disease, Chronic Obstructive 1 Precancerous Conditions 1 Overall Survival 1 Ototoxicity 1 Neoplastic Cells, Circulating 1 Neoplasms, Plasma Cell 1 Nasopharyngeal Carcinoma 1 Melanoma 1

Interventions

pembrolizumab 254 Nivolumab 232 Ipilimumab 210 aldesleukin 119 Cyclophosphamide 117 Interleukin-2 88 trametinib 74 dabrafenib 66 Dacarbazine 62 Vemurafenib 60 fludarabine 59 Temozolomide 59 fludarabine phosphate 52 Biopsy 43 Radiosurgery 41 sargramostim 39 Bevacizumab 39 incomplete Freund's adjuvant 35 binimetinib 34 Paclitaxel 32 Magnetic Resonance Spectroscopy 32 atezolizumab 31 Specimen Handling 31 Radiotherapy 31 Cisplatin 31 Introns 30 cobimetinib 29 Blood Specimen Collection 29 encorafenib 28 Carboplatin 27

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06785974 2025-01-22

SPIRAL

Erasmus Medical Center

Phase 4 Not yet recruiting

Melanoma, Atherosclerosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡